Neuphoria Therapeutics Inc (NEUP) Live Share Price, Invest From India

Neuphoria Therapeutics Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

Day's Low
$5.27
Day's Price Range
$5.38
$5.38
2.04%
Downside
52 Week's Low
52 Week's High
$3.65
52-Week Price Range
$21.40
$5.38
32.25%
Downside
297.78%
Upside

Neuphoria Therapeutics Inc share price movements today

Previous Close: $5.29
Open: $5.30
Volume: 231.4K
Day's Low - High: $5.27 - $5.38
52 Week Low - High: $3.65 - $21.40

Neuphoria Therapeutics Inc Historical Returns

1 Month Return: + 24.88 %
3 Month Return: + 34.54 %
1 Year Return: + 8.38 %
3 Year Return: 0 %
5 Year Return: 0 %

Neuphoria Therapeutics Inc Stock Fundamentals & Key Indicators

Check Neuphoria Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.5M

EPS (TTM)

-4.07

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-26.07%

Neuphoria Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuphoria Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neuphoria Therapeutics Inc	NA	$28.5M	NA	NA	-37.79%
Alnylam Pharmaceuticals Inc	BUY	$40.2B	127.94%	75.85	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.9B	99.08%	25.18	32.94%
BeiGene, Ltd.	NA	$33.1B	NA	120.44	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.6B	40.83%	17.13	29.65%

Stock Returns calculator for Neuphoria Therapeutics Inc Stock including INR - Dollar returns

The Neuphoria Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neuphoria Therapeutics Inc investment value today

Current value as on today

₹1,21,253

Returns

₹21,253

(+21.25%)

Returns from Neuphoria Therapeutics Inc Stock

₹8,032 (+8.03%)

Dollar Impact

₹13,220 (+13.22%)

Indian Investors' Interest in Neuphoria Therapeutics Inc Stock

Search interest for Neuphoria Therapeutics Inc Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:71% versus previous 30 day period

Neuphoria Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	1	23	-15	-	-
Gross Profit	0	-	0	0	0	0	23	-15	0	0
Operating Income	-5	-6	-3	-8	-5	-5	19	-1,133	-8	-2
EBITDA	-1	-6	-3	-3	-1	-3	18	-846	-14	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	-	0	0
Income Before Tax	-1	-6	-4	-4	-1	-3	17	-846	-15	1
Income Tax Expense	0	0	0	0	0	0	0	-468	0	0
Net Income	-1	-6	-4	-4	-1	-3	17	-378	-14	1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-293.24%	75.08%	2414.30%	0.00%	0.00%

Neuphoria Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	7	18	3	0	0	0	0	-	-	23
Gross Profit	-5	2	-13	-4	-2	-1	0	0	0	22
Operating Income	-28	-13	-30	-20	-11	-12	-28	-22	-26	-1
EBITDA	-22	-9	-30	-13	-4	-6	-28	-21	-22	0
Interest Expense	1	1	1	1	1	1	0	0	-	-
Depreciation	-	-	-	-	-	1	0	0	0	-
Income Before Tax	-26	-12	-34	-17	-8	-9	-29	-22	-23	-1
Income Tax Expense	-9	-6	-8	-6	-3	-1	-6	0	0	0
Net Income	-16	-6	-26	-10	-6	-6	-22	-14	-23	0
Net Profit Margin	-207.75%	-36.58%	-668.33%	-1477.09%	-15255.78%	-931.70%	-8253.62%	0.00%	0.00%	-2.36%

Neuphoria Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	-2	-2	0	-1	11	-378	-9	1
Operating Cash Flow	-3	-3	-3	-4	-3	11	73	-3	-6
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	5	1	7	0	0	1	1,527	3	14
Change in Cash	2	-1	4	-4	-3	12	14,271	-3	8

Neuphoria Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-	-	-	-4	-6	-14	-14	-15	-369
Operating Cash Flow	-1	-15	-10	-2	-5	-14	-9	-14	77
Investing Cash Flow	0	0	0	0	0	0	0	-	-
Financing Cash Flow	-1	1	3	-3	23	18	2	15	1,528
Change in Cash	-2	-13	-7	-6	17	3	-15	0	1,601

Insights on Neuphoria Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, NEUP stock has moved up by 24.9%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 17.3%

About Neuphoria Therapeutics Inc

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105 for the treatment of cancer. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; and Kv3.1/3.2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders. The company has a collaboration with Merck & Co., Inc. to develop a7 receptor positive allosteric modulators targeting cognitive dysfunction associated with alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Burlington, Massachusetts.

Organisation	Neuphoria Therapeutics Inc
Headquarters	100 Summit Drive, Burlington, MA, United States, 01803
Industry	Biotechnology
CEO	Dr. Spyridon Papapetropoulos M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Neuphoria Therapeutics Inc

Name	Title
Mr. Adrian Hinton BEC, F.C.A.	Financial Controller
Mr. Rajeev Chandra B.Com., C.A., M.B.A.	Company Secretary
Dr. Spyridon Papapetropoulos M.D., Ph.D.	Interim CEO & Executive Director
Ms. Elizabeth Doolin M.Sc.	Senior Vice President of Clinical Development
Dr. Julie Kerner Ph.D.	Senior Vice President of Business Operations

FAQs

What is Neuphoria Therapeutics Inc share price today?

Neuphoria Therapeutics Inc share price today is $5.38 as on May 6, 2026 at 1:29 am IST at the close of the market. Neuphoria Therapeutics Inc share today touched a day high of $5.38 and a low of $5.27.

What is the 52 week high and 52 week low for Neuphoria Therapeutics Inc share?

Neuphoria Therapeutics Inc share touched a 52 week high of $21.4 on October 7, 2025 and a 52 week low of $3.65 on December 29, 2025. Neuphoria Therapeutics Inc stock price today i.e. May 6, 2026 at 1:29 am IST is closed at $5.38,which is 74.86% down from its 52 week high and 47.60% up from its 52 week low.

What is Neuphoria Therapeutics Inc's market capitalisation today?

Neuphoria Therapeutics Inc market capitalisation is $0.00T as on May 6, 2026 at 1:29 am IST.

How to invest in Neuphoria Therapeutics Inc Stock (NEUP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuphoria Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuphoria Therapeutics Inc Shares that will get you 0.2788 shares as per Neuphoria Therapeutics Inc share price of $5.38 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Neuphoria Therapeutics Inc Stock (NEUP) from India?

Indian investors can start investing in Neuphoria Therapeutics Inc (NEUP) shares with as little as ₹94.61 or $1 (as of May 6, 2026 at 6:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Neuphoria Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 6:38 pm IST). Based on Neuphoria Therapeutics Inc share’s latest price of $5.38 as on May 6, 2026 at 1:29 am IST, you will get 1.8587 shares of Neuphoria Therapeutics Inc. Learn more about fractional shares .